Table 1. British Columbia Cancer Agency Chemotherapy Management Guidelines.
Stage | |||||||||
---|---|---|---|---|---|---|---|---|---|
IA (M−) | IA (M+) | IB | II | IIIA | IIIB | IIIC | IVA | IVA | |
Endometrioid | |||||||||
Grade 1 | − | − | − | −/+ | −/+ | + | + | + | + |
Grade 2 | − | − | − | −/+ | + | + | + | + | + |
Grade 3 | − | − | + | + | + | + | + | + | + |
Non-endometrioid | |||||||||
Serous | − | + | + | + | + | + | + | + | + |
Clear cell | − | − | + | + | + | + | + | + | + |
M1 carcinosarcoma | − | + | + | + | + | + | + | + | + |
M+, myometrial invasion present; M−, myometrial invasion not present; +, chemotherapy recommended; −, no chemotherapy recommended; +/−, chemotherapy optional.